MedTrace Logo

Chronic Pain OneSheet Clinical Trial

NCT04295135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2024-05-24

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to determine whether and how having access to the Chronic Pain OneSheet clinical decision support tool in Epic affects the ordering, prescribing, goal-setting, risk monitoring, and outcome measuring behavior of participating primary care providers (PCPs) in visits with patients with chronic pain conditions. The investigators will also assess whether access to the Chronic Pain OneSheet results in PCPs making chronic pain treatment decisions that are more concordant with the Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain.

Conditions

Interventions

BEHAVIORAL

Chronic Pain OneSheet

The Chronic Pain OneSheet (OneSheet) is an EHR decision support tool that uses behavioral economics to increase adoption of chronic pain guideline recommendations. OneSheet works by aggregating and structuring information that is already collected, that PCPs often need while caring for patients with chronic pain conditions. By aggregating and structuring this information in a more convenient manner, the goal of OneSheet is to make the information that is important in clinical decision making more readily available, and to reduce the amount of time that PCPs need to spend locating this information.

Sponsors & Collaborators

  • Eskenazi Health

    collaborator OTHER

  • Wake Forest University

    collaborator OTHER

  • Wake Forest University Health Sciences

    collaborator OTHER

  • University of Florida

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Indiana University

    lead OTHER

Principal Investigators

  • Christopher A Harle, PhD · Indiana University

  • Olena Mazurenko, MD, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-04
Primary Completion
2022-05-18
Completion
2022-05-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04295135 on ClinicalTrials.gov